Intecept Pharmaceuticals Inc entered the industry of in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 325412, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the BOTH market.
To acquire more information, please contact Mark Pruzanski by calling (817) 557-0852 during business hours. You can also write to the business’ Single Location at 18 Desbrosses St, New York City, New York NY 10013. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Intecept Pharmaceuticals Inc |
| Representative: | Mark Pruzanski |
| Place of Business: | 18 Desbrosses St, New York City, NY 10013 |
| Contact Number: | (817) 557-0852 |
| Type of Service: | |
| SIC Number: | 2834 |
| NAICS Number: | 325412 |
| Locality: | Single Location |
| Market Type: | B2B & B2C |
| Began: | 2005 |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Intecept Pharmaceuticals Inc is a company operating from New York, New York providing professional and relevant BOTH variables. It was founded in 2005 and registered with the SIC code 2834 as , and with the NAICS code 325412 as .
With a current employee count of 1 to 4, Intecept Pharmaceuticals Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Mark Pruzanski at (817) 557-0852 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 18 Desbrosses St in New York City, New York 10013 and can be engaged online through the company website at , the company Twitter , and Facebook page .